Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its availability have become key topics for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its expensive nature presents a significant challenge to man